Ophthalmic Imaging Systems (“OIS”) designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. The company has 25 years experience in the ophthalmic imaging business and is the leading provider of ophthalmic digital imaging systems.
The company today announced that it will launch two new products and improvements to the OIS EMR and OIS PM solutions at the American Academy of Ophthalmology ’s 113th annual meeting to be held October 24-27 in San Francisco. The two new products are specifically targeted to address the shift in healthcare demand due to aging populations and the rapid rise in diabetic-related eye disease.
The new product launches are:
OIS EyeScan – The OIS EyeScan is the first totally new imaging device the company has launched in a few years. It is a revolutionary new portable imaging device has wide-ranging functionality that is capable of imaging both the anterior and posterior segment of the eye. This innovative device is powered by the market-leading OIS WinStation software and once fully integrated with the OIS Symphony Image Management Solution will deliver more functionality than has ever been available in an imaging device.
OIS Symphony Digital Reporter – Combining Digital Reporter with OIS’ market-leading OIS Symphony Web Image Management System will help back-office users of digital documentation streamline their operations which will effectively increase their productivity.
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Stock Report http://video.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment